Diane M. Demas

Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition

W. Baumann, Wei He, A. Shajahan-Haq, 2020, Journal of the Royal Society Interface.

MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer

R. Clarke, L. Hilakivi-Clarke, Katherine L. Cook, 2014, Molecular Cancer.

The role of SLC7A5 (LAT1) in endocrine therapy resistant breast cancer

R. Clarke, R. Hu, S. Sengupta, 2019 .

Modeling breast cancer proliferation, drug synergies, and alternating therapies

W. Baumann, Wei He, A. Shajahan-Haq, 2022, bioRxiv.

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer

S. Demo, K. Nephew, R. Clarke, 2019, Front. Oncol..

Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors

Lu Jin, Wei He, A. Shajahan-Haq, 2021, Frontiers in Oncology.

SLCs contribute to endocrine resistance in breast cancer: role of SLC7A5 (LAT1)

R. Clarke, R. Hu, S. Sengupta, 2019, bioRxiv.

Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells

W. He, Chunyan Hou, A. Shajahan-Haq, 2023, bioRxiv.